Detection of KPC-216, a Novel KPC-3 Variant, in a Clinical Isolate of <i>Klebsiella pneumoniae</i> ST101 Co-Resistant to Ceftazidime-Avibactam and Cefiderocol

Detection of KPC-216, a Novel KPC-3 Variant, in a Clinical Isolate of <i>Klebsiella pneumoniae</i> ST101 Co-Resistant to Ceftazidime-Avibactam and Cefiderocol

Background: Carbapenemase-producing <i>Klebsiella pneumoniae</i> (CP-KP) represents a global threat to public health, with limited antimicrobial therapeutic options. In this study, we analyzed a ceftazidime/avibactam (CAZ-AVI)-resistant <i>K. pneumoniae</i> isolate obtained f...

Full description

Bibliographic Details
Main Authors: Maria Giufrè, Giulia Errico, Maria Del Grosso, Michela Pagnotta, Bernardetta Palazzotti, Milva Ballardini, Annalisa Pantosti, Marcello Meledandri, Monica Monaco
Format: Article
Language:English
Published: MDPI AG 2024-05-01
Series:Antibiotics
Subjects:
ceftazidime-avibactam
cefiderocol
cross-resistance
KPC-216
ESKAPE
Online Access:https://www.mdpi.com/2079-6382/13/6/507

Internet

https://www.mdpi.com/2079-6382/13/6/507

Similar Items